Search for: bacteria

EnglishFrançaisSlovenščinaBiHHrvatski

bacteria

PROPOLIS AND BACTERIUM INFLAMMATION

Antibacterial effect of propolis is more expressed on the gram-positive (Streptococcus SP. ,Staphylococcus SP.) than on the gram-negative bacterium (Salmonella, Escherichia coli, Proteus spp., Pseudomonas aeruginosa) (1). In the antibacterial effect more ingredients of propolis are participating.

Propolis stops the multiplication of bacterium by damaging its cytoplasm, cytoplasm membrane and cellular membrane, causes the partial bacterialisis and inhibits the synthesis of proteins (2). When it’s taken with the combination of majority of antibiotics (the penicillin, ampicillin, gentamicin, penicillin G, streptomycin, tetracycline, kloksacilin, ceftriakson, chloramphenicol, neomycin, monomicin, oleandomicin, polimiksin, doksiciklin, vancomicin, cefradin, polimiksin B) antibacterical effect is stronger and period of recovery is shorter (3,4,5).

It is interesting that in case when antibiotics (the chloramphenicol, gentamicin, netilmicin, tetracycline, vancomycin, ciprofloksacin) are not functioning on some bacteria (for example Staphylococcus aureus) in combination with propolis they have the antibacterial effect (6,7,8). In cases when antibiogram shows (in vitro) that propolis doesn’t have any effect on some gram-negative bacterias (Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli, Pseudomonas aeruginosa), in the organism (in vivo) propolis stimulates immunological system for prevention of inflammatory processes that they cause (9).

In bacterial inflammation (Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Streptococcus pyogenes) of upper respiratory tracts or in the mouth cavity (Enterococcus faecalis, Streptococcus salivarius, Streptococcus sanguinis, Streptococcus bribe, Streptococcus mutans, Streptococcus sobrinus, Candida albicans, Lactobacillus casei) antibiotic therapy can be enhanced in the combination with propolis (10, 11, 12, 13, 14).

Considering the growing resistance (the resistance) of bacterias to antibiotics, its obvious that the revolutionary time of antibiotics is slowly comming to an end (15). Sinergistic enlargement of antibiotic effect in combination with propolis, even in cases when antibiotics alone are not functioning, points out to the promising role of propolis in antibacterial therapy. Since propolis is not toxic, it does not provoke the resistance in the organism and does not damage the normal intestinal fluorine.

Antibacterial effect on the gram-positive bacterias is not significantly different in samples of propolis from the same plant collected in different seasons. In spite of differences in the chemical structure, propolis of different fitogeografical origin is showing the similar antibacterical, antifungus and antivirus activity. Which is why propolis is pharmacologicaly valuable like natural mixture of all substances it contains (NATIVE PROPOLIS), and not like the source of new compounds against microorganisms (16,17,18).

There’s an interesting experience of one known footballer after the operation of ankle joint. Process started with high fever which clearly suggested that it is a strong inflammatory process. The inflammatory process of the ancle joint was caused by MRSA infection (golden staphylococcus , Methicillin-Resistent Staphylococcus aureus). Because that bacterium is very resistant to antibiotics, inflammation which starts lasts very long (becomes chronical) and is very difficult to cure. Thats what happend in this case. Continuation of such state would have the serious consequence on the health, and certainly on career. When he started to take large doses of native propolis (3x3 capsules daily) with the prescribed antibiotic therapy, the inflammatory process completely calmed down. Today he plays football again. 

It was scientifically established that propolis effects on next bacterias in a way that it stops their multiplication (bacteriostaticly) or it kills it (bactericidal): Bacillus larvae (19), Bacillus subtilis (20), Helicobacter pylori (21,22), MRSA (the Methicillin-Resistent Staphylococcus aureus), Mycobacterium tuberculosis (23), Staphylococcus SP, Staphylococcus aureus (9,4,20,18,24,4,25), Streptococcus SP., Streptococcus faecalis, Streptomyces (26,34), With. sobrinus, mutans, cricetus (3,27,28), Saccharomyces cerevisiae (29), Escherichia coli (9,4,24,30), Salmonella (30), Bacteroides nodosus (31,32), Klebsiella pneumoniae (17,33), Streptococcus pyogenes (6,25), Proteus vulgaris (1, 17), Pseudomonas aeruginosa (17), Streptococcus agalactiae (9), Paenibacillus larvae (35).

LITERATURE:

1. Journal of the Royal Society of Medicine 1990 Mar;83(3):159-60.
2. Planta Medica 1994 Jun,60(3):222-7.
3. Z Naturforsch [C] 1999 Jul-Aug;54(7-8):549-53.
4. Arzneimittelforschung 1993 May;43(5):607-9.
5. Microbiol Res. 2006;161(4):327-33. Epub 2006 Jan 19.
6. Journal of the Royal Society of Medicine 1990 Mar;83(3):159-60.
7. Mem Inst Oswaldo Cruz. 2005 Aug;100(5):563-6. Epub 2005 Sep 15.
8. Ophthalmic Res. 2005 Nov-Dec;37(6):328-34. Epub 2005 Aug 6.
9. Planta Medica 1994 Jun,60(3):222-7.
10. J Chemother. 2006 Apr;18(2):164-71.
11. Anaerobe. 2007 Jun-Aug;13(3-4):140-5. Epub 2007 Mar 7.
12. Anaerobe. 2002 Feb;8(1):9-15.
13. Drug Dev Ind Pharm. 2006 Feb;32(2):229-38.
14. Microbiol Res. 2005;160(2):189-95.
15. J Ethnopharmacol. 2005 Dec 1;102(3):371-6. Epub 2005 Aug 3.
16. Acta Pharm. 2003 Dec;53(4):275-85.
17. Vaccine 1992;10(12):817-23.
18. Chung Kuo Chung Yao Tsa Chih 1991 Aug;16(8):481-2, 512.
19. Apiacta 1982;17:16-20.
20. Z Naturforsch [C] 2000 Sep-Oct;55(9-10):778-84.
21. Przegl Lek 2000;57(4):191-4.
22. Phytomedicine 2001 Jan;8(1):16-23.
23. Journal of the Royal Society of Medicine Mar. 1990;83(3):159-60.
24. Z Naturforsch [C] 2001 Jan-Feb;56(1-2):82-8.
25. Antibiotiki 1981 Apr;26(4):268-71.
26. Pharmazie 1986 Feb;41(2):131-32.
27. Caries Research 1991;25(5):347-51.
28. Oral Microbiol Immunol 2002 Dec;17(6):337-43.
29. Elsevier Science publishers 1988:439-446.
30. Vopr Med Khim 1986;32(3):45-48.
31. Apimondia Publishing House, Bucharest, Romania, 1978;149-50.
32. Apiacta 1989;XXIV(3):80-81.
33. Apidologie 1991;22(2):155-62.
34. J Ethnopharmacol 2001 Feb;74(2):105-12.
35. J Invertebr Pathol. 2007 Oct 17.

PROPOLIS AND IMMUNOLOGICAL SYSTEM

For centuries propolis is being mentioned as the strengthener of immunological system. Newer researches are undoubtedly confirming such traditional experiences (1). Results are indicating that propolis amplifies immunological mechanisms for the production of specific and nonspecific defensive matters with which it is confronting illness and interrupts its progress, independently of native and acquired immunological capacities. Professionally, such effect is defined as immunomodulational or immunoregulational activity, and popularly like the strengthening of immunological system.

It has been proved that propolis in vitro prevents the growth of bacterium by not allowing dividing of bacterial stations (2). But propolis in vivo (in the organism), stimulates the immunological system for production of the specific and nonspecific matters from the macrophage which stops the illness, even in cases when in vitro propolis does not function on some bacterias (3,4). Which is why in bacterial inflammations the activity of antibiotics in the combination with propolis is more efficient than antibiotic alone (5,6).

In viral illnesses propolis is directly functioning on viruses by not allowing their multiplication and at the same time it encourages the immunological system on the accelerated production of antibodies (7,8,9,10,11).

In tumor illnesses it encourages immunological system on the strengthened activity of killer-cells and other specific and nonspecific defensive matters and at the same time moves the death mechanism of tumor cells (1,12). Its antimetastasis characteristics are also binded to the immunological activity (13).

Protective activity of propolis in radioactive radiations is manifested by stimulation of macrophage to produce interferons and specific cytokins which points to the immunological reaction of organism (14).

In some parasites which are causing inflammatory bowel disease, prevention with propolis significantly calms down the inflammatory process, which happens because of increased quantity of interferons in blood. That’s why the combination of medicine (the antiprotozoic) and propolis is more efficient than the activity of the single therapeutic (15).

Research with genetic method of DNA chips at the “Ruder Boskovic” Institute in Zagreb proved that native propolis eliminates all noxious substances (carcinogenic, poisons, free radicals, pollutants) introduced or created in the organism, and repairs damage in cells. Excellent years-long experiences in health protection with native propolis are only confirming the scientific facts.

LITERATURE:
1. J Ethnopharmacol. 2007 Aug 15;113(1):1-14. Epub 2007 May 22.
2. Planta Medica 1994 Jun,60(3):222-7.
3. Vaccine 1992;10(12):817-23.
4. Antibiotiki 1981 Apr;26(4):268-71.
5. Z Naturforsch [C] 1999 Jul-Aug;54(7-8):549-53.
6. Z Naturforsch [C] 1999 Jul-Aug;54(7-8):549-53.
7. Isr Med Assoc J 2002 Nov;4(11 Suppl):923-7.
8. Drugs Exp Clin Res. 1997;23(2):89-96.
9. Microbiologica. 1990 Jul;13(3):207-13.
10. J Nat Prod. 1994 May;57(5):644-7.
11. Int Immunopharmacol. 2004 Jul;4(7):975-82.
12. Planta Med. 2006 Jan;72(1):20-7.
13. J Ethnopharmacol. 2003 Feb;84(2-3):265-73.
14. Am J Chin Med. 2005;33(2):231-40.
15. J Egypt Soc Parasitol. 2007 Aug;37(2 Suppl):691-710.

Tests on mice have shown that propolis prevents the forming of cataract and enhances the antioxidative defence of blood and lens. The same antioxidative as well as anti-inflammatory…

More...

Effect of propolis on particular organs
Choose an organ and click for effect description